Ampligen in Chronic Fatigue Syndrome

Status Available

Clinical Trial Summary

This is an open label study of Ampligen in patients with chronic fatigue syndrome.

Clinical Trial Description

An Open-Label Study of Poly I: Poly C12U (Ampligen®) in Patients with Severely Debilitating Chronic Fatigue Syndrome (CFS)/Myalgic Encephalomyelitis (ME). The FDA approved the study for cost recovery. Patients enrolled in the study are responsible for costs related to the therapy, e.g., drug cost, infusion cost, cost of supplies, diagnostic and other laboratory testing. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00215813
Study type	Expanded Access
Source	AIM ImmunoTech Inc.
Contact	Diane Young
Phone	352-448-7797
Email	diane.young@aimimmuno.com
Status	Available
Phase

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05454683` - Melatonin and Zinc Administration on Cardinal Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	N/A
Completed	`NCT01686074` - Motor Control in Chronic Fatigue Syndrome and Fibromyalgia	N/A
Completed	`NCT02075489` - Acupressure for Pain Management and Fatigue Relief in Gulf War Veterans	N/A
Completed	`NCT01651754` - Humoral and Cellular Immune Responses After Influenza Vaccination in Patients With Postcancer Fatigue and in Patients With Chronic Fatigue Syndrome	N/A
Completed	`NCT00540254` - Behavioral Insomnia Therapy With Chronic Fatigue Syndrome	Phase 1/Phase 2
Active, not recruiting	`NCT00071162` - Genetics of Fibromyalgia	N/A
Withdrawn	`NCT04870476` - Feasibility and Acceptability of the Internet-delivered Treatment "One Step at the Time" for Bodily Distress Syndrome	N/A
Completed	`NCT05730660` - Quercetin Phytosome® Chronic Fatigue Syndrome	N/A
Recruiting	`NCT04542161` - Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Phase 2
Recruiting	`NCT03807973` - Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes.	Phase 1
Recruiting	`NCT05719493` - Effectiveness and Health Benefits of a Nutritional, Chronobiological and Physical Exercise Intervention in Fibromyalgia and Chronic Fatigue Syndrome (SYNCHRONIZE +)	N/A
Recruiting	`NCT05967052` - Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation	Phase 2
Terminated	`NCT01730495` - Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome	Phase 2
Completed	`NCT01650636` - Patient-Partner Stress Management Effects on Chronic Fatigue Syndrome Symptoms and Neuroimmune Process	N/A
Completed	`NCT01156909` - B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome	Phase 2
Completed	`NCT01046370` - A Pilot Study of Amygdala Retraining Program in Patients With Chronic Fatigue Syndrome, Chronic Fatigue and Fibromyalgia	N/A
Completed	`NCT00100412` - Hyporeactivity and Gulf War Illness	N/A
Recruiting	`NCT06128967` - A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The REVIVE Trial	Phase 3
Completed	`NCT02669212` - Myalgic Encephalomyelitis Chronic Fatigue at the National Institutes of Health	N/A
Not yet recruiting	`NCT06011135` - Exploring Worry in CFS/ME